Abiopharma

BIO-RAD LABORATORIES, INC. (BIO)

Symbol	BIO
Name	BIO-RAD LABORATORIES, INC.
Sector	INDUSTRIALS
Region	North America
Industry	Biotechnology: Laboratory Analytical Instruments
Address	1000 ALFRED NOBEL DRIVE, HERCULES, California, 94547, United States
Telephone	+1 510 724-7000
Fax	—
Email	—
Website	https://www.bio-rad.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000012208
Description	Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. Additional info from NASDAQ: Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

2026-09-09 22:47

Director Allison Schwartz 🟡 adjusted position in 603 shares (3 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $386.11 Transaction Date: Sep 04, 2026 | Filing ID: 000004

2026-09-09 22:46

BARRY JAMES 🟡 adjusted position in 3.5K shares (3 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $386.11 Transaction Date: Sep 04, 2026 | Filing ID: 000004

2026-09-09 22:46

EVRAN SEDAT 🟡 adjusted position in 3.4K shares (3 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $386.11 Transaction Date: Sep 04, 2026 | Filing ID: 000002

2026-09-09 22:45

ENGELHARDT EVA ANETTE 🟡 adjusted position in 3.5K shares (3 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $386.11 Transaction Date: Sep 04, 2026 | Filing ID: 000006

2026-09-09 22:44

Mehta Rajat 🟡 adjusted position in 3.9K shares (3 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $386.11 Transaction Date: Sep 04, 2026 | Filing ID: 000002

2026-09-09 22:42

Lakkaraju Roop Kalyan 🟡 adjusted position in 5.0K shares (3 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $386.11 Transaction Date: Sep 04, 2026 | Filing ID: 000004

2026-09-09 22:42

Director SCHWARTZ NORMAN D 🟡 adjusted position in 12.5K shares (3 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $386.11 ($1.8M) Transaction Date: Sep 04, 2026 | Filing ID: 000004

2026-09-03 21:41

BARRY JAMES 🟡 adjusted position in 154 shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $380.96 Transaction Date: Sep 01, 2026 | Filing ID: 000002

2026-09-03 21:38

Director Allison Schwartz 🟡 adjusted position in 43 shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $380.96 Transaction Date: Sep 01, 2026 | Filing ID: 000002

2026-09-03 21:35

Director SCHWARTZ NORMAN D 🟡 adjusted position in 2.3K shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $380.96 Transaction Date: Sep 01, 2026 | Filing ID: 000002